New Approach to Deliver Value-Based Procurement Rolled Out Across NHS in England

Key Takeaways

• 40% cost weight, 60% outcome and sustainability metrics
• NHS trusts receive central training and senior‑management backing
• Three‑year team will refine VBP based on pilot feedback
• Scotland and Wales are watching for possible replication
• Essity sees VBP as catalyst for whole‑care pathway redesign

Pulse Analysis

The NHS’s shift to value‑based procurement marks a strategic departure from traditional price‑first buying. By capping whole‑life cost influence at 40% and mandating that at least 60% of evaluation criteria reflect patient outcomes, experience and environmental impact, the government aims to align spending with clinical effectiveness. This model responds to longstanding criticism that the NHS has prioritized low‑cost items over holistic value, a practice that can inflate long‑term expenditures through sub‑optimal device performance.

Implementation will hinge on robust training and cultural change within procurement teams. Senior management endorsement, as highlighted by David Lawson, is intended to empower clinicians to engage early, ensuring that clinical evidence drives decision‑making. The three‑year support team overseeing the 13 pilot projects will gather data to fine‑tune scoring algorithms, creating a feedback loop that could accelerate adoption across community and secondary care settings. Early adopters like Essity anticipate that VBP will trigger broader pathway reviews, integrating device selection with patient flow and cost‑saving opportunities.

If successful, England’s VBP framework could become a template for the devolved nations and beyond. International health systems grappling with rising device costs and sustainability pressures are watching the NHS experiment closely. The initiative also dovetails with the UK’s 10‑Year NHS Plan, reinforcing a policy narrative that values outcomes over price. As evidence accumulates, the model may evolve into a cornerstone of value‑based healthcare, influencing not only procurement but also reimbursement and innovation incentives across the sector.